China Universal Asset Management »

Silence Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $83k 14k 6.08
2025-09-30 $43k 8.2k 5.19
2025-06-30 $55k 9.4k 5.80
2025-03-31 $27k 9.4k 2.82
2024-12-31 $69k 10k 6.88

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Inc-cl A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Alphabet Inc-cl C Common Stock (GOOG)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Proshares Ultra Gold Etp (UGL)
Netflix Common Stock (NFLX)
Spdr Gold Minishares Trust Etp (GLDM)

View all positions for China Universal Asset Management

Top funds holding Silence Therapeutics

TCG Crossover Management
Siren
Redmile Group
Lombard Odier Asset Management
Vivo Capital
Nantahala Capital Management
Frazier Life Sciences Management
Nextech Invest
Ikarian Capital
Cantor Fitzgerald, L. P.
5AM Venture Management
Millennium Management
Boothbay Fund Management
SG Americas Securities
UBS Group

View all funds holding Silence Therapeutics